Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$301K Buy
935
+17
+2% +$5.56K 0.03% 137
2024
Q2
$287K Sell
918
-124
-12% -$36.4K 0.03% 129
2024
Q1
$296K Hold
1,042
0.03% 121
2023
Q4
$300K Hold
1,042
0.04% 119
2023
Q3
$280K Hold
1,042
0.04% 113
2023
Q2
$231K Hold
1,042
0.03% 109
2023
Q1
$252K Hold
1,042
0.04% 109
2022
Q4
$274K Hold
1,042
0.05% 103
2022
Q3
$235K Buy
+1,042
New +$253K 0.05% 108
2021
Q3
Sell
-1,284
Closed -$313K 163
2021
Q2
$313K Sell
1,284
-30
-2% -$7.38K 0.06% 130
2021
Q1
$327K Buy
+1,314
New +$314K 0.07% 137
2020
Q1
Sell
-1,492
Closed -$360K 129
2019
Q4
$360K Sell
1,492
-832
-36% -$183K 0.11% 129
2019
Q3
$450K Sell
2,324
-4,180
-64% -$802K 0.15% 135
2019
Q2
$1.2M Sell
6,504
-1,544
-19% -$276K 0.36% 95
2019
Q1
$1.53M Sell
8,048
-449
-5% -$85.7K 0.45% 82
2018
Q4
$1.65M Sell
8,497
-1,395
-14% -$272K 0.49% 54
2018
Q3
$2.05M Buy
9,892
+524
+6% +$103K 0.45% 84
2018
Q2
$1.73M Buy
9,368
+1,365
+17% +$241K 0.4% 88
2018
Q1
$1.36M Sell
8,003
-1,988
-20% -$365K 0.3% 98
2017
Q4
$1.74M Buy
9,991
+389
+4% +$68.8K 0.36% 77
2017
Q3
$1.79M Sell
9,602
-150
-2% -$26.6K 0.41% 75
2017
Q2
$1.68M Buy
9,752
+99
+1% +$16.1K 0.45% 79
2017
Q1
$1.58M Sell
9,653
-23
-0.2% -$3.82K 0.65% 44
2016
Q4
$1.42M Sell
9,676
-5,684
-37% -$855K 0.62% 50
2016
Q3
$2.56M Buy
15,360
+940
+7% +$159K 1.21% 24
2016
Q2
$2.19M Buy
14,420
+1,910
+15% +$297K 1.14% 27
2016
Q1
$1.88M Buy
+12,510
New +$1.86M 1.02% 30

Other funds holding AMGN

Pegasus Partners's AMGN Position: Q3 2024 in Review

Pegasus Partners increased its Amgen (AMGN) stake by 1.9% in Q3 2024, buying an estimated $5.56K and bringing the position to 935 shares worth $301K. The position accounts for 0.03% of the portfolio, ranked #137.

Pegasus Partners first reported a position in AMGN in Q1 2016 and has held it in 27 quarters since. The position peaked at $2.56M in Q3 2016. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Pegasus Partners held 935 shares of Amgen worth $301K as of Q3 2024.
  • Pegasus Partners bought 17 Amgen shares in Q3 2024, an estimated $5.56K.
  • Amgen made up 0.03% of Pegasus Partners's portfolio in Q3 2024, its #137 holding.
  • Pegasus Partners first reported a position in Amgen in Q1 2016 and has held it in 27 quarters since.
  • Pegasus Partners's Amgen position peaked at $2.56M in Q3 2016.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Pegasus Partners's 13F filing for Q3 2024, filed 1 Nov 2024.